CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson
Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.CME information and select publications here.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Hematologic Oncology Update
Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review
CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review
Get summaries like this every morning.
Free AI-powered recaps of Hematologic Oncology Update and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.